|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2009-07-17- -2009-07-21 Sale |
2009-07-21 4:58 pm | SUNESIS PHARMACEUTICALS INC | SNSS | WARBURG PINCUS EQUITY PARTNERS LP WARBURG PINCUS & CO Warburg Pincus Partners LLC WARBURG PINCUS LLC (10% owner) | 465,480 | $0.277 | $128,951 | 3,204,075 (Direct) |
View |
| 2009-07-15- -2009-07-16 Sale | 2009-07-17 4:04 pm | SUNESIS PHARMACEUTICALS INC | SNSS | WARBURG PINCUS EQUITY PARTNERS LP WARBURG PINCUS & CO Warburg Pincus Partners LLC WARBURG PINCUS LLC (10% owner) | 177,220 | $0.308 | $54,576 | 3,669,555 (Direct) |
View |
| 2009-07-13- -2009-07-14 Sale | 2009-07-15 4:11 pm |
SUNESIS PHARMACEUTICALS INC | SNSS | WARBURG PINCUS EQUITY PARTNERS LP WARBURG PINCUS & CO Warburg Pincus Partners LLC WARBURG PINCUS LLC (10% owner) | 457,300 | $0.3604 | $164,800 | 3,846,775 (Direct) |
View |
| 2005-09-27 Purchase |
2006-02-14 11:59 am | SUNESIS PHARMACEUTICALS INC | SNSS | BIOGEN IDEC INC BIOGEN IDEC MA INC (10% owner) | 714,286 | $7 | $5,000,002 | 2,912,022 (Indirect) |
View |
| 2005-09-30 Purchase(A) |
2005-12-22 9:47 pm | SUNESIS PHARMACEUTICALS INC | SNSS | MAYFIELD IX MAYFIELD IX MANAGEMENT LLC MAYFIELD ASSOCIATES FUND III L P MAYFIELD VIII MANAGEMENT LLC UNGER WILLIAM D AUKEN WENDELL G VAN III FONG KEVIN A MYERS FRANK G JR DALAL YOGEN K HEIDRICH A GRANT III (10% owner) | 70,000 | $7 | $490,000 | 64,940 (Direct Indirect) |
View |
| Transaction & Date | Reported Date |
Exercisable Expiration | Company | Symbol | Insider Relationship | Shares Traded | Conversion Price |
Shares Ownership | Filing |
| 2009-10-30 Purchase |
2009-11-03 7:28 pm |
N/A N/A |
SUNESIS PHARMACEUTICALS INC | SNSS | BAY CITY CAPITAL LLC Bay City Capital Management V LLC Bay City Capital Fund V, L.P. Bay City Capital Fund V Co-Investment Fund LP (10% owner) | 326,936 | $0.22 | 980,809 (Direct) | View |
| 2009-10-30 Purchase | 2009-11-03 7:28 pm |
N/A N/A |
SUNESIS PHARMACEUTICALS INC | SNSS | BAY CITY CAPITAL LLC Bay City Capital Management V LLC Bay City Capital Fund V, L.P. Bay City Capital Fund V Co-Investment Fund LP (10% owner) | 6,230 | $0.22 | 18,690 (Direct) |
View |
| 2009-10-30 Purchase | 2009-11-03 7:28 pm |
2009-10-30 2016-10-30 |
SUNESIS PHARMACEUTICALS INC | SNSS | BAY CITY CAPITAL LLC Bay City Capital Management V LLC Bay City Capital Fund V, L.P. Bay City Capital Fund V Co-Investment Fund LP (10% owner) | 3,269,360 | $0.22 | 3,269,360 (Direct) |
View |
| 2009-10-30 Purchase |
2009-11-03 7:28 pm | 2009-10-30 2016-10-30 | SUNESIS PHARMACEUTICALS INC | SNSS | BAY CITY CAPITAL LLC Bay City Capital Management V LLC Bay City Capital Fund V, L.P. Bay City Capital Fund V Co-Investment Fund LP (10% owner) | 62,300 | $0.22 | 62,300 (Direct) | View |
| 2009-10-30 Purchase |
2009-11-03 5:41 pm | N/A N/A | SUNESIS PHARMACEUTICALS INC | SNSS | HURWITZ EDWARD (Director 10% owner) | 152,576 | $0.22 | 457,728 (Indirect) |
View |
| 2009-10-30 Purchase | 2009-11-03 5:41 pm | N/A N/A |
SUNESIS PHARMACEUTICALS INC | SNSS | HURWITZ EDWARD (Director 10% owner) | 10,246 | $0.22 | 30,739 (Indirect) | View |
| 2009-10-30 Purchase | 2009-11-03 5:41 pm |
N/A N/A | SUNESIS PHARMACEUTICALS INC | SNSS | HURWITZ EDWARD (Director 10% owner) | 3,760 | $0.22 | 11,280 (Indirect) |
View |
| 2009-10-30 Purchase | 2009-11-03 5:41 pm | 2009-10-30 2016-10-30 | SUNESIS PHARMACEUTICALS INC | SNSS | HURWITZ EDWARD (Director 10% owner) | 1,525,760 | $0.22 | 1,525,760 (Indirect) | View |
| 2009-10-30 Purchase |
2009-11-03 5:41 pm | 2009-10-30 2016-10-30 | SUNESIS PHARMACEUTICALS INC | SNSS | HURWITZ EDWARD (Director 10% owner) | 102,460 | $0.22 | 102,460 (Indirect) | View |
| 2009-10-30 Purchase |
2009-11-03 5:41 pm |
2009-10-30 2016-10-30 |
SUNESIS PHARMACEUTICALS INC | SNSS | HURWITZ EDWARD (Director 10% owner) | 37,600 | $0.22 | 37,600 (Indirect) |
View |
| 2009-10-30 Purchase |
2009-11-03 5:35 pm |
N/A N/A | SUNESIS PHARMACEUTICALS INC | SNSS | Misfeldt Dayton (Director 10% owner) | 326,936 | $0.22 | 980,809 (Indirect) |
View |
| 2009-10-30 Purchase | 2009-11-03 5:35 pm | N/A N/A | SUNESIS PHARMACEUTICALS INC | SNSS | Misfeldt Dayton (Director 10% owner) | 6,230 | $0.22 | 18,690 (Indirect) |
View |
| 2009-10-30 Purchase | 2009-11-03 5:35 pm |
2009-10-30 2016-10-30 | SUNESIS PHARMACEUTICALS INC | SNSS | Misfeldt Dayton (Director 10% owner) | 3,269,360 | $0.22 | 3,269,360 (Indirect) |
View |
| 2009-10-30 Purchase | 2009-11-03 5:35 pm | 2009-10-30 2016-10-30 |
SUNESIS PHARMACEUTICALS INC | SNSS | Misfeldt Dayton (Director 10% owner) | 62,300 | $0.22 | 62,300 (Indirect) |
View |
| 2009-10-30 Purchase |
2009-11-03 5:31 pm |
N/A N/A | SUNESIS PHARMACEUTICALS INC | SNSS | Ketchum Steven B (Sr. Vice President, R & D) | 3,331 | $0.22 | 9,994 (Direct) | View |
| 2009-10-30 Purchase | 2009-11-03 5:31 pm | 2009-10-30 2016-10-30 | SUNESIS PHARMACEUTICALS INC | SNSS | Ketchum Steven B (Sr. Vice President, R & D) | 33,310 | $0.22 | 33,310 (Direct) |
View |
| 2009-10-30 Purchase | 2009-11-03 5:23 pm | N/A N/A | SUNESIS PHARMACEUTICALS INC | SNSS | BJERKHOLT ERIC (Sr. VP, CFO & Corp. Secretary) | 3,331 | $0.22 | 9,994 (Indirect) |
View |
| 2009-10-30 Purchase | 2009-11-03 5:23 pm | 2009-10-30 2016-10-30 |
SUNESIS PHARMACEUTICALS INC | SNSS | BJERKHOLT ERIC (Sr. VP, CFO & Corp. Secretary) | 33,310 | $0.22 | 33,310 (Indirect) |
View |
| 2009-10-30 Purchase | 2009-11-03 5:16 pm | N/A N/A |
SUNESIS PHARMACEUTICALS INC | SNSS | Swisher Daniel N JR (President and CEO Director) | 6,663 | $0.22 | 19,989 (Indirect) | View |
| 2009-10-30 Purchase |
2009-11-03 5:16 pm | 2009-10-30 2016-10-30 | SUNESIS PHARMACEUTICALS INC | SNSS | Swisher Daniel N JR (President and CEO Director) | 66,630 | $0.22 | 66,630 (Indirect) |
View |
| 2009-10-30 Purchase |
2009-11-03 5:07 pm |
N/A N/A | SUNESIS PHARMACEUTICALS INC | SNSS | ALTA BIOPHARMA PARTNERS III LP ALTA BIOPHARMA MANAGEMENT III LLC ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC PENHOET EDWARD DELEAGE JEAN CHAMPSI FARAH (10% owner) | 152,576 | $0.22 | 457,728 (Direct) |
View |
| 2009-10-30 Purchase | 2009-11-03 5:07 pm | N/A N/A | SUNESIS PHARMACEUTICALS INC | SNSS | ALTA BIOPHARMA PARTNERS III LP ALTA BIOPHARMA MANAGEMENT III LLC ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC PENHOET EDWARD DELEAGE JEAN CHAMPSI FARAH (10% owner) | 10,246 | $0.22 | 30,739 (Indirect) | View |
| 2009-10-30 Purchase |
2009-11-03 5:07 pm | N/A N/A | SUNESIS PHARMACEUTICALS INC | SNSS | ALTA BIOPHARMA PARTNERS III LP ALTA BIOPHARMA MANAGEMENT III LLC ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC PENHOET EDWARD DELEAGE JEAN CHAMPSI FARAH (10% owner) | 3,760 | $0.22 | 11,280 (Indirect) |
View |
| 2009-10-30 Purchase | 2009-11-03 5:07 pm |
2009-10-30 2016-10-30 | SUNESIS PHARMACEUTICALS INC | SNSS | ALTA BIOPHARMA PARTNERS III LP ALTA BIOPHARMA MANAGEMENT III LLC ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC PENHOET EDWARD DELEAGE JEAN CHAMPSI FARAH (10% owner) | 1,525,760 | $0.22 | 1,525,760 (Direct) | View |
| 2009-10-30 Purchase | 2009-11-03 5:07 pm | 2009-10-30 2016-10-30 |
SUNESIS PHARMACEUTICALS INC | SNSS | ALTA BIOPHARMA PARTNERS III LP ALTA BIOPHARMA MANAGEMENT III LLC ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC PENHOET EDWARD DELEAGE JEAN CHAMPSI FARAH (10% owner) | 102,460 | $0.22 | 102,460 (Indirect) |
View |
| 2009-10-30 Purchase | 2009-11-03 5:07 pm |
2009-10-30 2016-10-30 | SUNESIS PHARMACEUTICALS INC | SNSS | ALTA BIOPHARMA PARTNERS III LP ALTA BIOPHARMA MANAGEMENT III LLC ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC PENHOET EDWARD DELEAGE JEAN CHAMPSI FARAH (10% owner) | 37,600 | $0.22 | 37,600 (Indirect) | View |
| 2009-10-30 Purchase |
2009-11-03 4:52 pm |
2009-10-30 2016-10-30 |
SUNESIS PHARMACEUTICALS INC | SNSS | TRAINOR III EUGENE A (10% owner) | 3,331,660 | $0.22 | 3,331,660 (Indirect) | View |
| 2009-10-30 Purchase | 2009-11-03 4:52 pm | N/A N/A | SUNESIS PHARMACEUTICALS INC | SNSS | TRAINOR III EUGENE A (10% owner) | 333,166 | $0 | 999,499 (Indirect) | View |
| 2009-10-30 Purchase |
2009-11-03 4:52 pm |
2009-10-30 2016-10-30 |
SUNESIS PHARMACEUTICALS INC | SNSS | LINEHAN CHARLES M (10% owner) | 3,331,660 | $0.22 | 3,331,660 (Indirect) |
View |
| 2009-10-30 Purchase | 2009-11-03 4:52 pm | N/A N/A | SUNESIS PHARMACEUTICALS INC | SNSS | LINEHAN CHARLES M (10% owner) | 333,166 | $0 | 999,499 (Indirect) | View |
| 2009-10-30 Purchase | 2009-11-03 4:52 pm | 2009-10-30 2016-10-30 | SUNESIS PHARMACEUTICALS INC | SNSS | KOLLURI KRISHNA KITTU (10% owner) | 3,331,660 | $0.22 | 3,331,660 (Indirect) |
View |
| 2009-10-30 Purchase | 2009-11-03 4:52 pm |
N/A N/A | SUNESIS PHARMACEUTICALS INC | SNSS | KOLLURI KRISHNA KITTU (10% owner) | 333,166 | $0 | 999,499 (Indirect) |
View |
| 2009-10-30 Purchase | 2009-11-03 4:52 pm | 2009-10-30 2016-10-30 |
SUNESIS PHARMACEUTICALS INC | SNSS | KERINS PATRICK J (10% owner) | 3,331,660 | $0.22 | 3,331,660 (Indirect) |
View |
| 2009-10-30 Purchase | 2009-11-03 4:52 pm |
N/A N/A |
SUNESIS PHARMACEUTICALS INC | SNSS | KERINS PATRICK J (10% owner) | 333,166 | $0 | 999,499 (Indirect) | View |
| 2009-10-30 Purchase | 2009-11-03 4:51 pm | 2009-10-30 2016-10-30 |
SUNESIS PHARMACEUTICALS INC | SNSS | DRANT RYAN D (10% owner) | 3,331,660 | $0.22 | 3,331,660 (Indirect) |
View |
| 2009-10-30 Purchase | 2009-11-03 4:51 pm |
N/A N/A |
SUNESIS PHARMACEUTICALS INC | SNSS | DRANT RYAN D (10% owner) | 333,166 | $0 | 999,499 (Indirect) |
View |
| 2009-10-30 Purchase | 2009-11-03 4:51 pm |
2009-10-30 2016-10-30 | SUNESIS PHARMACEUTICALS INC | SNSS | BASKETT FOREST (10% owner) | 3,331,660 | $0.22 | 3,331,660 (Indirect) | View |
| 2009-10-30 Purchase | 2009-11-03 4:51 pm | N/A N/A |
SUNESIS PHARMACEUTICALS INC | SNSS | BASKETT FOREST (10% owner) | 333,166 | $0 | 999,499 (Indirect) |
View |
| 2009-10-30 Purchase |
2009-11-03 4:51 pm |
2009-10-30 2016-10-30 |
SUNESIS PHARMACEUTICALS INC | SNSS | Growth Equity Opportunities Fund, LLC New Enterprise Associates 12, Limited Partnership NEA 12 GP, LLC NEWHALL CHARLES W III KRAMLICH C RICHARD BARRIS PETER J PERRY MARK W BARRETT M JAMES NEA Partners 12, Limited Partnership SANDELL SCOTT D (10% owner) | 3,331,660 | $0.22 | 3,331,660 (Direct) | View |
| 2009-10-30 Purchase |
2009-11-03 4:51 pm |
N/A N/A |
SUNESIS PHARMACEUTICALS INC | SNSS | Growth Equity Opportunities Fund, LLC New Enterprise Associates 12, Limited Partnership NEA 12 GP, LLC NEWHALL CHARLES W III KRAMLICH C RICHARD BARRIS PETER J PERRY MARK W BARRETT M JAMES NEA Partners 12, Limited Partnership SANDELL SCOTT D (10% owner) | 333,166 | $0 | 999,499 (Direct) | View |
| 2009-08-31 Option Award | 2009-09-02 8:01 pm | N/A 2019-08-31 |
SUNESIS PHARMACEUTICALS INC | SNSS | Ketchum Steven B (Sr. Vice President, R & D) | 450,000 | $0.49 | 450,000 (Direct) |
View |
| 2009-08-31 Option Award | 2009-09-02 7:54 pm | N/A 2019-08-31 |
SUNESIS PHARMACEUTICALS INC | SNSS | BJERKHOLT ERIC (Sr. VP and CFO) | 450,000 | $0.49 | 450,000 (Direct) |
View |
| 2009-08-31 Option Award | 2009-09-02 7:47 pm | N/A 2019-08-31 | SUNESIS PHARMACEUTICALS INC | SNSS | Swisher Daniel N JR (President and CEO Director) | 750,000 | $0.49 | 750,000 (Direct) |
View |
| 2009-07-31 Option Award | 2009-08-04 4:16 pm |
N/A 2019-07-30 |
SUNESIS PHARMACEUTICALS INC | SNSS | Kim Helen Susan (Director) | 70,000 | $0.41 | 70,000 (Direct) | View |
| 2009-07-31 Option Award | 2009-08-04 4:12 pm | N/A 2019-07-30 | SUNESIS PHARMACEUTICALS INC | SNSS | Pearce Homer L (Director) | 90,000 | $0.41 | 90,000 (Direct) |
View |
| 2009-07-31 Option Award |
2009-08-04 4:07 pm |
N/A 2019-07-30 | SUNESIS PHARMACEUTICALS INC | SNSS | Fust Matthew (Director) | 90,000 | $0.41 | 90,000 (Direct) |
View |
| 2009-07-31 Option Award |
2009-08-04 4:04 pm | N/A 2019-07-30 | SUNESIS PHARMACEUTICALS INC | SNSS | STUMP DAVID C (Director) | 90,000 | $0.41 | 90,000 (Direct) |
View |
| 2009-07-31 Option Award |
2009-08-04 4:01 pm |
N/A 2019-07-30 | SUNESIS PHARMACEUTICALS INC | SNSS | YOUNG JAMES W (Director) | 90,000 | $0.41 | 90,000 (Direct) | View |
| 2009-07-24 Option Award |
2009-07-28 5:42 pm | N/A 2019-07-23 | SUNESIS PHARMACEUTICALS INC | SNSS | Kim Helen Susan (Director) | 30,000 | $0.3425 | 30,000 (Direct) |
View |
| 2009-06-18 Option Award |
2009-06-19 5:51 pm | N/A 2019-06-17 |
SUNESIS PHARMACEUTICALS INC | SNSS | HURWITZ EDWARD (Director) | 10,000 | $0.3799 | 10,000 (Direct) | View |
| 2009-06-18 Option Award |
2009-06-19 5:40 pm |
N/A 2019-06-17 | SUNESIS PHARMACEUTICALS INC | SNSS | Misfeldt Dayton (Director) | 10,000 | $0.3799 | 10,000 (Direct) |
View |
| 2009-04-03 Purchase | 2009-04-07 3:07 pm | 2009-04-03 2016-04-02 |
SUNESIS PHARMACEUTICALS INC | SNSS | EVNIN ANTHONY B (Director) | 133,266 | $0.22 | 133,266 (Indirect) | View |
| 2009-04-03 Purchase |
2009-04-07 3:07 pm | N/A N/A | SUNESIS PHARMACEUTICALS INC | SNSS | EVNIN ANTHONY B (Director) | 133,266 | $0 | 133,266 (Indirect) | View |
| 2008-06-30 Option Award | 2008-07-02 8:23 pm |
N/A 2018-06-30 |
SUNESIS PHARMACEUTICALS INC | SNSS | Pierce Valerie L (SVP & General Counsel) | 67,500 | $1.44 | 67,500 (Direct) | View |
| 2008-06-05 Option Award | 2008-06-06 2:31 pm | 2008-07-05 2018-06-05 |
SUNESIS PHARMACEUTICALS INC | SNSS | GOLDBY STEVEN D (Director) | 10,000 | $1.77 | 10,000 (Direct) | View |
| 2008-06-05 Option Award | 2008-06-05 5:19 pm |
2008-07-05 2018-06-05 | SUNESIS PHARMACEUTICALS INC | SNSS | Wells James A (Director) | 10,000 | $1.77 | 10,000 (Direct) | View |
| 2008-06-05 Option Award | 2008-06-05 5:10 pm | 2008-07-05 2018-06-05 |
SUNESIS PHARMACEUTICALS INC | SNSS | FODOR STEPHEN P A (Director) | 10,000 | $1.77 | 10,000 (Direct) | View |
| 2008-06-05 Option Award | 2008-06-05 4:52 pm |
2008-07-05 2018-06-05 |
SUNESIS PHARMACEUTICALS INC | SNSS | LEFF JONATHAN S (Director 10% owner) | 10,000 | $1.77 | 10,000 (Direct) | View |
| 2007-09-13 Option Award | 2007-09-14 6:57 pm | 2007-10-13 2017-09-13 | SUNESIS PHARMACEUTICALS INC | SNSS | McDowell Robert Scott (Vice President, Research) | 60,000 | $2.59 | 60,000 (Direct) |
View |
| 2007-09-13 Option Award |
2007-09-14 5:40 pm |
2007-10-13 2017-09-13 |
SUNESIS PHARMACEUTICALS INC | SNSS | ADELMAN DANIEL C MD (Sr. VP, Development and CMO) | 90,000 | $2.59 | 90,000 (Direct) |
View |
| 2006-11-30 Option Award | 2006-12-04 4:52 pm |
2006-12-31 2016-11-30 |
SUNESIS PHARMACEUTICALS INC | SNSS | Winter Daryl B (SVP of I.P./Corp. Secretary) | 45,000 | $4.62 | 45,000 (Direct) |
View |
| 2005-09-27 Purchase |
2006-02-14 11:59 am |
N/A N/A |
SUNESIS PHARMACEUTICALS INC | SNSS | BIOGEN IDEC INC BIOGEN IDEC MA INC (10% owner) | 1,250,000 | $0 | 0 (Indirect) | View |
| 2005-09-27 Purchase | 2006-02-14 11:59 am |
N/A N/A |
SUNESIS PHARMACEUTICALS INC | SNSS | BIOGEN IDEC INC BIOGEN IDEC MA INC (10% owner) | 2,916,667 | $0 | 0 (Indirect) |
View |
| 2005-09-30 Purchase |
2005-12-22 9:47 pm |
N/A N/A |
SUNESIS PHARMACEUTICALS INC | SNSS | MAYFIELD IX MAYFIELD IX MANAGEMENT LLC MAYFIELD ASSOCIATES FUND III L P MAYFIELD VIII MANAGEMENT LLC UNGER WILLIAM D AUKEN WENDELL G VAN III FONG KEVIN A MYERS FRANK G JR DALAL YOGEN K HEIDRICH A GRANT III (10% owner) | 2,945,000 | $0 | 0 (Direct) |
View |
| 2005-09-30 Purchase | 2005-12-22 9:47 pm |
N/A N/A |
SUNESIS PHARMACEUTICALS INC | SNSS | MAYFIELD IX MAYFIELD IX MANAGEMENT LLC MAYFIELD ASSOCIATES FUND III L P MAYFIELD VIII MANAGEMENT LLC UNGER WILLIAM D AUKEN WENDELL G VAN III FONG KEVIN A MYERS FRANK G JR DALAL YOGEN K HEIDRICH A GRANT III (10% owner) | 1,096,153 | $0 | 0 (Direct) | View |
| 2005-09-30 Purchase | 2005-12-22 9:47 pm | N/A N/A |
SUNESIS PHARMACEUTICALS INC | SNSS | MAYFIELD IX MAYFIELD IX MANAGEMENT LLC MAYFIELD ASSOCIATES FUND III L P MAYFIELD VIII MANAGEMENT LLC UNGER WILLIAM D AUKEN WENDELL G VAN III FONG KEVIN A MYERS FRANK G JR DALAL YOGEN K HEIDRICH A GRANT III (10% owner) | 593,750 | $0 | 0 (Direct) |
View |
| 2005-09-30 Purchase | 2005-12-22 9:47 pm |
N/A N/A | SUNESIS PHARMACEUTICALS INC | SNSS | MAYFIELD IX MAYFIELD IX MANAGEMENT LLC MAYFIELD ASSOCIATES FUND III L P MAYFIELD VIII MANAGEMENT LLC UNGER WILLIAM D AUKEN WENDELL G VAN III FONG KEVIN A MYERS FRANK G JR DALAL YOGEN K HEIDRICH A GRANT III (10% owner) | 155,000 | $0 | 0 (Indirect) | View |
| 2005-09-30 Purchase |
2005-12-22 9:47 pm |
N/A N/A |
SUNESIS PHARMACEUTICALS INC | SNSS | MAYFIELD IX MAYFIELD IX MANAGEMENT LLC MAYFIELD ASSOCIATES FUND III L P MAYFIELD VIII MANAGEMENT LLC UNGER WILLIAM D AUKEN WENDELL G VAN III FONG KEVIN A MYERS FRANK G JR DALAL YOGEN K HEIDRICH A GRANT III (10% owner) | 57,693 | $0 | 0 (Indirect) |
View |
| 2005-09-30 Purchase |
2005-12-22 9:47 pm | N/A N/A | SUNESIS PHARMACEUTICALS INC | SNSS | MAYFIELD IX MAYFIELD IX MANAGEMENT LLC MAYFIELD ASSOCIATES FUND III L P MAYFIELD VIII MANAGEMENT LLC UNGER WILLIAM D AUKEN WENDELL G VAN III FONG KEVIN A MYERS FRANK G JR DALAL YOGEN K HEIDRICH A GRANT III (10% owner) | 31,250 | $0 | 0 (Indirect) |
View |
| 2005-09-30 Purchase |
2005-10-04 4:32 pm |
N/A N/A | SUNESIS PHARMACEUTICALS INC | SNNS | CREDIT SUISSE CREDIT SUISSE FIRST BOSTON EQUITY PARTNERS, L.P. CREDIT SUISSE FIRST BOSTON EQUITY PARTNERS (BERMUDA), L.P. EMA PARTNERS FUND 2000, L.P. EMA PRIVATE EQUITY FUND 2000, L.P. CREDIT SUISSE FIRST BOSTON U.S. EXECUTIVE ADVISORS, L.P. CREDIT SUISSE FIRST BOSTON ADVISORY PARTNERS, LLC CREDIT SUISSE FIRST BOSTON (BERMUDA) LTD HEMISPHERE PRIVATE EQUITY PARTNERS, LTD. HEMISPHERE PRIVATE EQUITY PARTNERS CHARITABLE TRUST (10% owner) | 6,458,333 | $0 | 0 (Indirect) |
View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Thu, 05 Nov 2009 20:57:27 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |